Invention Grant
- Patent Title: Pegylated carfilzomib compounds
-
Application No.: US16675134Application Date: 2019-11-05
-
Publication No.: US10675353B2Publication Date: 2020-06-09
- Inventor: Gary Luehr , Shabbir T. Anik , Ge Peng , Irina Dotsenko , Pasit Phiasivongsa , Dante Romanini
- Applicant: AMGEN INC.
- Applicant Address: US CA Thousand Oaks
- Assignee: AMGEN INC.
- Current Assignee: AMGEN INC.
- Current Assignee Address: US CA Thousand Oaks
- Agent Joseph F. Reidy; Elsa D. Lemoine
- Main IPC: C07D405/12
- IPC: C07D405/12 ; A61K38/07 ; A61K47/60 ; A61K9/00 ; C08G65/333
Abstract:
The present invention provides a method of treating multiple myeloma using polymeric pegylated carfilzomib compounds, and pharmaceutically acceptable salts thereof, of Formula I wherein R1, R2, linker, PEG, n and o are as defined herein.
Public/Granted literature
- US20200069808A1 PEGYLATED CARFILZOMIB COMPOUNDS Public/Granted day:2020-03-05
Information query
